Search live federal opportunities

1. Option #1 is hereby executed for the period July 2, 2026 through July 1, 2027. 2. All other terms and conditions remain unchanged.

Modification to exercise Option Year 1 for Lamotrigine ER Tablets is attached.

SPE2D2-26-D-0012 Sertraline Tablets Follow-On Award

Exercise of Option 1 for Azithromycin Suspension.

SPE2D2-26-D-0010 Celecoxib Capsules

Fexofenadine Tablets SPE2D2-25-D-0005 Option 1

National Contract Award to AvKARE, LLC. (SPE2D2-26-D-0002) for Telmisartan Tablets originally solicited under SPE2D2-24-R-0015.

SPE2D2-26-D-0004 Morphine IR & ER Tablets Award

Award for Fluconazole Tablets solicited under SPE2D2-25-R-0009.

NATIONAL CONTRACT SPE2D2-22-D-0144 VALSARTAN

Award for Solifenacin solicited under SPE2D2-25-D-0017.

SPE2D2-22-D-0150 P00007 to invoke Option Year 3 SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders. SPE2D2-22-D-0150 P00005 to invoke Option Year 2 SPE2D2-22-D-0150 P00003 to invoke Option Year 1 SPE2D2-22-D-0150 P00002 To incorporate Drug

NATIONAL CONTRACT SPE2D223D0011 CLOBETASOL PROPIONATE 0.05% SOLUTION

Sertraline HCL Tablets 25MG in 30, 90, 180 and 500 Count bottles, Sertraline HCL Tablets in 50MG in 30, 90, 180, and 500 Count bottles and Sertraline HCL Tablets in 30, 60, 90, 180 and 500 Count bottlles.

SPE2D2-25-D-0012 Pramipexole Tablets Award

SPE2D2-25-D-0007 Hydrocodone-Acetaminophen Award

Methylphenidate Award

Modification SPE2D223D0012 P00004 to exercise Option Year 1.

SPE2D2-24-D-0007 Finasteride Tablets Award

NATIONAL CONTRACT SPE2D223D0005 LISINOPRIL HCTZ TABLETS

NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER

NATIONAL CONTRACT SPE2D2-23-D-0001 ESTRADIOL TABLETS

AWARD OF CELECOXIB CAPSULES DLA TROOP SUPPORT NATIONAL CONTRACT

AWARD OF METAXALONE TABLETS DLA TROOP SUPPORT NATIONAL CONTRACT